Manufacturing and analytics for lentivirus and AAV vectors: a visual and audio guide

Cell & Gene Therapy Insights 2021; 7(3), 917

10.18609/cgti.2021.122

Published: 22 August 2021
Infographic

With the successful translation of cell and gene therapies into the clinic, demand for viral vectors has increased significantly. As a result, the need for scalable, cost-effective viral vector manufacturing processes, and improved methods of purification and analytics, has become apparent. Here we show the manufacturing processes and analytical testing for adeno-associated virus (AAV) and lentivirus (LV) side by side.